IQV — IQVIA HOLDINGS INC.
—
NYSE ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1478242 ·
Last close
$186.25
Market Cap
$31.09B
52W High
$190.68
52W Low
$154.50
ADV30
1,799,372
Next earnings
2026-07-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 4,151,000,000 | 1,355,000,000 | 565,000,000 | 274,000,000 | 29,675,000,000 | 1,947,000,000 | 23,326,000,000 |
| Dec 2025 | 4,364,000,000 | 1,436,000,000 | 651,000,000 | 514,000,000 | 29,944,000,000 | 1,980,000,000 | 23,314,000,000 |
| Sep 2025 | 4,100,000,000 | 1,373,000,000 | 573,000,000 | 331,000,000 | 28,727,000,000 | 1,814,000,000 | 22,439,000,000 |
| Jun 2025 | 4,017,000,000 | 1,323,000,000 | 538,000,000 | 266,000,000 | 28,632,000,000 | 2,039,000,000 | 22,846,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,704,000,000
Investing CF
$-2,196,000,000
Financing CF
$-325,000,000
CapEx
$-588,000,000
Dividends Paid
—
Buybacks
$-1,421,000,000
EPS Diluted TTM
$8.07
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$7,699,000,000
Inventory
—
Receivables
$3,375,000,000
ST Investments
$156,000,000
EBIT TTM
$2,352,000,000
Pretax Income TTM
$1,596,000,000
Interest Exp TTM
$756,000,000
Analysts
20
Yahoo Snapshot (yfinance, live)
Total Revenue
$16,632,000,512
EBITDA
$3,000,999,936
Free Cash Flow
$2,156,750,080
Enterprise Value
$44,899,860,480
Total Cash
$2,103,000,064
Total Debt
$16,216,999,936
Shares Out
166,900,000
Trailing EPS
$8.05
Book Value
$37.27
ROE
22.5%
ROA
5.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,310,000,000 | 2,287,000,000 | 1,360,000,000 | 29,944,000,000 | 23,314,000,000 | — | 2,654,000,000 |
| Dec 2024 | 15,405,000,000 | 2,269,000,000 | 1,373,000,000 | 26,899,000,000 | 20,832,000,000 | — | 2,716,000,000 |
| Dec 2023 | 14,984,000,000 | 2,061,000,000 | 1,358,000,000 | 26,681,000,000 | 20,569,000,000 | — | 2,149,000,000 |
| Dec 2022 | 14,410,000,000 | 1,827,000,000 | 1,091,000,000 | 25,337,000,000 | 19,572,000,000 | — | 2,260,000,000 |
TTM Snapshot
Revenues TTM
$14,503,000,000
NetIncome TTM
$1,210,000,000
OpCashFlow TTM
$0
Assets (Latest)
$26,899,000,000
Forward EPS
$14.19
Max Pain — expiry 2026-06-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $185.00 · spot: $186.25 · call volume: 37 · put volume: 1,158
Expected Move to 2026-06-18:
±$10.00
(5.37%) —
implied range
$176.25 –
$196.25
· ATM straddle on $185.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC /DE | $45.66B | $578.89 | — |
| INCY | INCYTE CORP | $20.62B | $103.23 | — |
| MEDP | Medpace Holdings, Inc. | $13.33B | $466.79 | — |
| ICLR | ICON PLC | $11.62B | $151.82 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $9.14B | $189.85 | — |
News headlines (Yahoo Finance, 1h cache)
Q1 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment
2026-06-09 19:26 · Yahoo
Is IQVIA Holdings Stock Outperforming the Dow?
2026-06-09 14:02 · Yahoo
ICON Stock Valuation vs Peers: Is ICLR Cheap Enough?
2026-06-08 15:48 · Yahoo
IQVIA Debt Refinance And EPS Upgrade Reshape Long Term Risk Profile
2026-06-06 10:05 · Yahoo
ICLR Earnings Reset: What the Accounting Probe Changed
2026-06-05 18:09 · Yahoo
Why Is Penumbra (PEN) Down 1.2% Since Last Earnings Report?
2026-06-05 15:30 · Yahoo
IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?
2026-06-04 15:30 · Yahoo
IQVIA Announces Pricing of Senior Notes
2026-06-04 14:51 · Yahoo
Is Veeva Stock Undervalued At $170?
2026-06-04 12:38 · Yahoo
IQVIA Announces Offering of Senior Notes
2026-06-03 06:53 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.